Neuropsychopharmacology
- Polydrug overdose mortality caused by synthetic opioids and stimulants: current sex- and age-specific trajectories in United States national data for 2018–20243 weeks ago
- Identifying behavioral and biological predictors of cannabis vapor self-administration in rats3 weeks ago
- Psychedelics produce enduring behavioral effects and functional plasticity through mechanisms independent of structural plasticity3 weeks ago
- Independent brain cortical signatures of risk for adolescent cannabis use and consequences of such use are moderated by sex3 weeks ago
- BDNF in ventrolateral orbitofrontal cortex to dorsolateral striatum circuit moderates alcohol consumption, seeking and relapse4 weeks ago
- Associations of neuromelanin in the substantia nigra with antipsychotic response in schizophrenia4 weeks ago
- Single-cell RNA sequencing uncovers molecular features underlying microglial lipid accumulation and depression-related behaviors in high-fat diet mouse model of obesity1 month ago
Journal of Psychopharmacology
- (-)-OSU6162 reduces freezing elicited by context-conditioned fear in rats7 days ago
- Exploring early add-on celecoxib treatment in OCD: Results from a preliminary randomized, double-blind, placebo-controlled trial1 week ago
- Intracerebroventricular knockdown of NPY1R disrupts NPY1R-GALR2/TrkB heteroreceptor complexes without affecting neuroplasticity or depressive-like behaviour1 week ago
- Statistical limitations of the claimed dose–response in “Dose–response efficacy and safety of lumateperone in bipolar depression: A preliminary meta-analysis of randomized controlled trials”1 week ago
- Effects of cannabidiol on behavioral and psychological symptoms of vascular dementia: A randomized, double-blind, placebo-controlled clinical trial2 weeks ago
- Long-term neurocognitive side effects of MDMA in recreational ecstasy users following sustained abstinence: A systematic review and meta-analysis2 weeks ago
- Role of chemokines in depression: Highlights on CX3CL1/CX3CR1 signaling3 weeks ago
European Neuropsychopharmacology
- Reply to the commentary on “Efficacy of pharmacogenetic (PGx)-guided antidepressant treatment on functional outcomes and quality of life in adults with anxiety and affective disorders: A systematic review and meta-analysis”2 weeks ago
- Activating β2-adrenergic receptor is a potential cross-disease therapeutic strategy for Alzheimer’s disease, obesity and type 2 diabetes2 weeks ago
- Patterns, predictors and outcomes of trajectories for subjective quality of life in patients with early psychosis: 12-year follow-up of the randomized controlled trial on extended early intervention2 weeks ago
- Persistent mortality gap in schizophrenia: current challenges and future directions2 weeks ago
- Efficacy, all-cause discontinuation, and safety of serotonergic psychedelics and MDMA to treat mental disorders: A living systematic review with meta-analysis4 weeks ago
- Chronic stress and brain kynurenine pathway: addressing unresolved issues with a meta-analytic approach of preclinical studies, translational implication for psychiatric disorders4 weeks ago
- Commentary on the article “Efficacy of pharmacogenetic-guided antidepressant treatment on functional outcomes and quality of life in adults with anxiety and affective disorders: A systematic review and meta-analysis”1 month ago